Company profile

Mvision AI Oy

Mvision AI Oy has 2 AI-enabled medical devices on the FDA list. The first decision was on October 18, 2024 and the most recent on September 4, 2025 (Dose+ (1.0)). Its most common review panel is Radiology (2 devices).

2AI devices
2024First decision
2025Latest decision
1Specialties

Related guides

Timeline

  1. Dose+ (1.0) · Radiology · MUJ
  2. Contour+ (MVision AI Segmentation) · Radiology · QKB